Clinical Trial Update: Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Endostar in combination with concurrent chemoradiotherapy for locally advanced cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Yong Zhang,MD | Conditions: Cervical Carcinoma | Phase 2 | Status: COMPLETED